Organized by
About 2nd International Conference on Diabetes & Endocrinology
The International Society for Renal Research is thrilled to announce the 2nd International Conference on Diabetes & Endocrinology scheduled for 25th & 26th April 2024 at Bangkok, Thailand | Hybrid Conference, welcoming participants and presenters from around the world. The 2nd ICDE 2024 aims to facilitate the exchange of knowledge and expertise, offering exceptional networking opportunities for medical and industry professionals. Esteemed scientists, physicians, surgeons, young researchers, industry representatives, and students in the diabetic medicine field will convene under one roof, fostering networking and global collaboration to advance future research. This conference serves as an international platform to showcase diabetes management research, foster idea exchange, and contribute to spreading disease management knowledge for societal benefit.
Early Bird Registration Deadline
15th January 2024
Abstract Submission Deadline
29th January 2024
Standard Registration Deadline
24th February 2024
Objective of the Conference
The theme "Diabetes and Endocrinology: Bridging Science & Clinical Practice" emphasizes the crucial connection between scientific advancements and their practical applications in the field of diabetes and endocrinology. This conference seeks to create a seamless integration between the latest research findings and their translation into effective clinical practices and driving progress in the understanding and management of diabetes and endocrine disorders.
- To provide a platform for researchers from around the world to share their research findings, best practices, and experiences.
- To promote awareness and understanding of diabetes and endocrine disorders, their causes, symptoms, and treatment options, among healthcare practitioners and the public.
- To provide ample opportunities for attendees to network, forming new professional connections and collaborations.
- Selective treatment methods to cure patients based on genetic understanding.
- To discuss and explore new strategies and innovations in patient care, management, and treatment modalities for individuals with diabetes and endocrine disorders.
Proceedings & Publications
Note : 2nd ICDE 2024 proceedings series will be submitted to the Web of Science Book Citation Index (BkCI) and to SCOPUS for evaluation and indexing.
The 2nd ICDE 2024 features
Renowned Keynote Speakers : Distinguished keynote speakers, often renowned experts in diabetes and endocrinology, are invited to deliver insightful talks on important issues and trends in the field.
Continuing Medical Education (CME) Credits : For healthcare professionals, CME credits may be offered for attending and participating in specific sessions, which can be important for maintaining professional certifications and licenses.
Research Presenting’s : Participants have the opportunity to present their own research findings, studies, and projects to a global audience. It's a chance to receive feedback, gain recognition, and contribute to the ongoing advancement of cancer research.
Scientific Sessions : The conference typically includes a series of scientific sessions covering various topics in diabetes and endocrinology. These sessions may include presentations by experts, research findings, and discussions on the latest developments in the field.
Industry Insights : Sessions dedicated to industry trends, innovations, and partnerships may be included to highlight the role of industry in advancing healthcare in these fields.
Awards and Recognitions : Conferences often include Best Paper & Poster Presentation awards to recognize outstanding research contributions in the field.
New research shows that automated insulin delivery technology could be a game changer for pregnant women with type 1 diabetes. The technology -- known as 'hybrid closed-loop technology' -- gives insulin doses as informed by a smartphone algorithm.
AI is being used to predict diabetes risk, monitor blood glucose levels, and assist in the management of the disease. Machine learning algorithms help to personalize treatment plans for patients.
Diabetic foot ulcers can now be added to the list of diabetic complications that may be avoided in persons with type 1 diabetes by early and intense blood glucose management.
A small clinical study has found that the oral medication verapamil may help preserve β-cell health in those newly diagnosed with type 1 diabetes.
Downloads
Conference Venue
Our 2nd ICDE is happening this year !
- Venue : Bangkok, Thailand | Virtual Conference
- Email : [email protected]
- Contact : +91-9363475928